Dianthus Therapeutics | MGTA - Pre Tax Profit

Stock Price
54.69
Daily Change
1.58 2.98%
Monthly
8.30%
Yearly
153.19%
Q1 Forecast
48.02

Dianthus Therapeutics reported $-36.76M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -23.77M 12.2M Jun/2025
Celltrion KRW 14.6B 180.89B Jun/2025
Cspc Pharmaceutical CNY 1.21B 110.04M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 8.54B 580M Dec/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Moderna USD -187M 631M Sep/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Pharma Mar EUR -4.08M 27.43M Sep/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Sartorius EUR 85M 14.1M Sep/2025
Tectonic Therapeutic USD -19.04M 25K Sep/2025
Tilray USD -1.39B 600.71M Mar/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025